Chronic Kidney Disease Learning Zone
Expert Opinion
In our series of expert videos on chronic kidney disease (CKD), Professor Hiddo Heerspink, Professor Vlado Perkovic and Dr George Bakris highlight:
- The unmet needs and challenges in CKD, including underdiagnosis
- The need for early CKD diagnosis and CKD screening strategies
- The importance of managing comorbid conditions
- CKD treatment goals and treatment options
- Newly approved treatments for CKD, including SGLT2 inhibitors and mineralocorticoid receptor antagonists
In this section
Professor Hiddo Heerspink
Professor Hiddo Heerspink from the University Medical Centre Groningen in the Netherlands highlights key unmet needs and clinical challenges for chronic kidney disease (CKD) and describes the DAPA-CKD trial, which led to approval of dapagliflozin for treatment of diabetic and non-diabetic kidney disease.
The most important unmet needs in chronic kidney disease
Why is early diagnosis of chronic kidney disease important?
Screening for chronic kidney disease and common comorbidities
Chronic kidney disease treatment goals and treatment
What is the evidence behind more recently approved treatments for CKD with and without diabetes?
Meet Professor Hiddo Heerspink and hear about his expertise in chronic kidney disease
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event